$PMN Cashflow Statement | Understand Stock

$PMN

$9.68 +$1.62 (20.1%) Live

$PMN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022
Cash flows from operating activities
Net (loss) income
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Share-based compensation expense
Foreign currency exchange gain
Change in fair value of financial instruments
Change in fair value of warrant liability
Depreciation of property and equipment
Amortization of debt discount and issuance costs
Amortization of intangible assets
Gain on extinguishment of convertible debt and derivative liability

Changes in operating assets and liabilities:
Prepaid expenses and other current assets
Accounts payable
Accrued liabilities
Net cash used in operating activities
Cash flows from investing activities
Purchase of short-term investments
Maturity of short-term investment
Purchase of property and equipment
Net cash used in investing activities

Cash flows from financing activities
Proceeds from issuance of Common Shares pursuant to 2025 and 2024 ATM offering, respectively, net of issuance costs
Proceeds from issuance of pre-funded warrants from July 22, 2025 Registered Direct Offering, net of issuance costs
Proceeds from issuance of warrants from October 2022 PIPE
Proceeds from exercise of pre-funded warrants
Net cash provided by financing activities

Effect of exchange rates on cash
Net (decrease) increase in cash
Cash at beginning of period
Cash at end of period
Noncash financing activities
Conversion of convertible debt and derivative liability to Series 1 Convertible Preferred Shares
Deferred share issuance costs related to January 2024 ATM Offering included in accounts payable and accrued liabilities as of December 31, 2023
Fair value of noncash compensation warrants issued to placement agents in the August 2023 PIPE
Reclassification of historical CAD denominated warrants from equity to liability
Reclassification of historical USD warrants from liability to equity
Reclassification of July 2024 PIPE warrants from liability to equity
Decrease in share-based compensation liability on CAD denominated share options increasing additional paid-in-capital
Deferred discount for fair value modification of warrants
July 22, 2025 Exercise of Discounted Warrants And Pipe Offering
July 28, 2025 Exercise of Discounted Warrants And Pipe Offering
Deferred discount issuance cost recognized on completion of PIPE
July 22, 2025 Exercise of Discounted Warrants And Pipe Offering
July 28, 2025 Exercise of Discounted Warrants And Pipe Offering

Supplemental disclosure of cash flow information
Cash paid for interest
Cash paid for other interest

Comments